MADISON GINIS: Open Payments
NPI 1144989310 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,449 in 35 payments from 16 companies in 2025. Trend: 2023 $553 · 2024 $330 · 2025 $1,449
Food & beverage: $1,449
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 4 | $239 |
| Regeneron Healthcare Solutions, Inc. | 5 | $196 |
| Incyte Corporation | 2 | $193 |
| Janssen Biotech, Inc. | 4 | $183 |
| Arcutis Biotherapeutics, Inc. | 2 | $162 |
| GENZYME CORPORATION | 3 | $106 |
| Amgen Inc. | 1 | $96 |
| Biogen, Inc. | 2 | $47 |
| Galderma Laboratories, L.P. | 2 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
Products named: DUPIXENT, ANZUPGO, Opzelura, TREMFYA, OTEZLA, ZURZUVAE, MYFEMBREE, Veozah.
Industry payments across AZ — which companies pay providers there.
